Value
8.3/10data confidence 83%| Component | Sub-score |
|---|---|
| P/S | 9.0 |
| EV/EBITDA | 6.1 |
| Fwd P/E | 9.4 |
| PEG | 8.2 |
| Analyst target | 9.0 |
- ▸Forward P/E: 9.2x
- ▸PEG: 0.79
- ▸Attractively valued
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Albemarle is posting strong earnings beats and 33% revenue growth with positive price momentum — but below-average business quality, 83% foreign revenue exposure, an asymmetry ratio just below the threshold, and a recent executive departure flag suggest patience is warranted before adding aggressively at current levels.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
The stock is above its 200-day moving average with rising on-balance volume and a strong MACD — technical conditions consistent with institutional buying interest supporting the price trend. Momentum breakdown | On-balance volume continuing to rise over the next three months, with the stock remaining above its 200-day moving average, would confirm the trend is intact. | ↑Improving |
| CounterThe setup is range-bound with RSI at 46, suggesting mid-range conditions that could resolve either direction; the asymmetry ratio falling just below the minimum threshold indicates the technical configuration is not yet strong enough for a high-conviction entry. | ||
Three of the past four quarters produced earnings beats averaging more than 76% above consensus, while revenue is growing at 33% year-over-year — placing the company at the top of its peer group for growth and demonstrating consistent ability to exceed expectations off a low base. Catalyst breakdown | Continued positive EPS surprise for the next two reporting periods and revenue growth sustaining above 20% would confirm the earnings recovery is durable. | →Stable |
| CounterThe single miss came in at 8.6% below estimates, and specialty chemical revenue can be volatile given commodity input swings and customer inventory cycles that can abruptly reverse recent momentum. | ||
At 83% of net sales derived from foreign countries, currency movements, tariff changes, and geopolitical disruption can materially impair reported results in ways that domestically focused specialty chemical producers do not face. Bear case | Foreign sales concentration declining below 70% or the company announcing material domestic revenue growth would reduce this geographic risk. | ↑Improving |
| CounterInternational presence across multiple geographies can be diversifying rather than concentrating if no single country dominates the foreign mix — the reported percentage alone does not reveal how the risk is distributed. | ||
Despite impressive earnings beats, underlying business quality is below par — return on assets is negligible and gross margin data is absent — leaving uncertainty about whether recent results reflect durable fundamental improvement or a cyclical conditions bounce. Key risks | Return on assets rising above 3% and gross margin becoming visible and positive for two consecutive quarters would signal the improvement is structural. | ↑Improving |
| CounterA Piotroski F-Score of 8 out of 9 is a strong indicator of financial health that often leads quality indices by several quarters; the current quality shortfall may reflect measurement lag rather than genuine business weakness. | ||
CounterThe setup is range-bound with RSI at 46, suggesting mid-range conditions that could resolve either direction; the asymmetry ratio falling just below the minimum threshold indicates the technical configuration is not yet strong enough for a high-conviction entry.
CounterThe single miss came in at 8.6% below estimates, and specialty chemical revenue can be volatile given commodity input swings and customer inventory cycles that can abruptly reverse recent momentum.
CounterInternational presence across multiple geographies can be diversifying rather than concentrating if no single country dominates the foreign mix — the reported percentage alone does not reveal how the risk is distributed.
CounterA Piotroski F-Score of 8 out of 9 is a strong indicator of financial health that often leads quality indices by several quarters; the current quality shortfall may reflect measurement lag rather than genuine business weakness.
| Component | Sub-score |
|---|---|
| P/S | 9.0 |
| EV/EBITDA | 6.1 |
| Fwd P/E | 9.4 |
| PEG | 8.2 |
| Analyst target | 9.0 |
| Component | Sub-score |
|---|---|
| ROE | 0.9 |
| ROA | 2.1 |
| Gross margin | 0.8 |
| Op margin | 10.0 |
| Net margin | 1.9 |
| Current ratio | 7.3 |
| FCF quality | 10.0 |
| Moat | 6.4 |
| Piotroski F | 8.9 |
| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
| Component | Sub-score |
|---|---|
| RSI | 3.5 |
| MACD | 10.0 |
| OBV | 1.0 |
| MA position | 1.0 |
| Volume | 4.4 |
| Component | Sub-score |
|---|---|
| LLM sentiment | 7.0 |
| Analyst rating | 7.5 |
| Price target | 9.8 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.9 |
| Component | Sub-score |
|---|---|
| value rank | 2.5 |
| quality rank | 3.5 |
| growth rank | 8.3 |
| Component | Sub-score |
|---|---|
| bollinger | 6.0 |
| support resistance | 6.4 |
| 52w position | 0.0 |
| gap | 6.0 |
| Component | Sub-score |
|---|---|
| short interest | 10.0 |
| days to cover | 10.0 |
| volatility | 3.4 |
| put call | 7.5 |
| implied vol | 2.4 |
| max pain risk | 7.0 |
| beta | 5.6 |
| debt equity | 9.2 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| dividend safety | 5.8 |
| news activity | 5.0 |
Maintain position. Not compelling to add more.
L4:PATH_F_HOLDSetup— — No clear chart pattern; technical signals are mixed
EdgeSector Rotation — Basic Materials sector out of favor, value=8.3
SuitabilitySpeculative — Drawdown -56% (>40% off 52w high)
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: ASYMMETRY:6.2>=1.5. Top dim: Growth at 10.0; weakest: Momentum at 4.0. No conviction either direction.
The strongest dimensions are Growth at 10.0, Value at 8.3, and Sentiment at 8.0; the weakest are Momentum at 4.0, Technical at 4.6, and Quality at 5.4. The V9 engine flagged 3 failed gates with 1 warning, producing an asymmetric reward-to-risk of 6.23 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifRevenue growth falls below 10% YoY for 2 consecutive quarters.
Trip ifStock breaks below the 200-day moving average and on-balance volume trends lower for more than 4 consecutive weeks.
Trip ifForeign revenue concentration falls below 60% for 2 consecutive reporting periods.
Trip ifReturn on assets rises above 4% for 2 consecutive quarters.